Siemens Healthineers Stock Price, News & Analysis
Company Description
Siemens Healthineers (OTC Link: SMMNY) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $63.3B.
SMMNY stock has declined 10.8% over the past year. Shares last traded at $22.48.
This page provides a comprehensive overview of SMMNY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Siemens Healthineers (SMMNY) stock last traded at $22.48, down 0.31% from the previous close. Over the past 12 months, the stock has lost 10.8%. At a market capitalization of $63.3B, SMMNY is classified as a large-cap stock with approximately 2.3B shares outstanding.
Latest News
Siemens Healthineers has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 9 with negative movement. Key topics include partnership. View all SMMNY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Siemens Healthineers (SMMNY) currently stands at 61.5 thousand shares, up 39.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 2546.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Siemens Healthineers (SMMNY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
SMMNY Company Profile & Sector Positioning
Siemens Healthineers (SMMNY) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SMMNY often look at related companies in the same sector, including Sonova Holding (SONVY), Cochlear Ord Adr (CHEOY), Getinge (GNGBY), Getinge (GNGBF), and Ambu A/S (AMBBY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SMMNY's relative position within its industry.